Anti-IL1B×IL1A hIgG1 Bispecific antibody(lutikizumab)
货号
GM-88265AB
规格
10μg
100 μg
1mg
立即询价
产品简介
相关产品
Anti-IL1B×IL1A hIgG1 Bispecific Antibody(lutikizumab) (Catalog # GM-88265AB) was immobilized at 6 μg/ml (100 μL/well). Increasing concentrations of Biotinylated Human IL-1 alpha Protein; His-Avi Tag (Catalog # GM-88251RP) were added.
Human IL-1 alpha Protein; His Tag (Catalog # GM-88245RP) was immobilized at 2 μg/ml (100 μL/well). Increasing concentrations of Anti-IL1B×IL1A hIgG1 Bispecific Antibody(lutikizumab) (Catalog # GM-88265AB) were added.
Human IL-1 beta Protein; His Tag (Catalog # GM-88248RP) was immobilized at 2 μg/ml (100 μL/well). Increasing concentrations of Anti-IL1B×IL1A hIgG1 Bispecific Antibody(lutikizumab) (Catalog # GM-88265AB) were added.
产品简介

Species Reactivity      Human

Clone                           lutikizumab

Source/Isotype           Human IgG1(L234A,L235A,D356E,L358M), kappa

Application                 Bioactivity-ELISA

Specificity                   Detects IL1B / IL1A

Gene                            IL1B; IL1A

Other Names              IL1B: IL-1, IL1-BETA, IL1F2, IL1beta
                                    IL1A: IL-1 alpha, IL-1A, IL1, IL1-ALPHA,

                                    IL1F1

Gene ID                       IL1B (3553);IL1A (3552)

Background                IL1A and IL1B belong to the same IL-1 cytokine family and are located adjacent to the Q13 region of human chromosome 2 Lutikizumab is an anti-il-1α and il-1β bivariate domain immunoglobulin that centrally targets two key proinflammatory cytokines, il-1α and il-1β, and has been shown to inhibit the production of il-1α and il-1β, a series of clinical studies have been carried out in the field of osteoarthritis (especially synovitis subtypes) by blocking IL-1 pathway-mediated inflammatory response through precise dual-target recognition and inhibition mechanisms, it provides a new direction for the treatment exploration of inflammatory phenotype osteoarthritis.

Storage                        Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation                Phosphate-buffered solution, pH 7.2-7.4.

Endotoxin                   < 1 EU/mg, determined by LAL gel clotting assay

相关产品
Anti-IL1B×IL1A hIgG1 Bispecific antibody(lutikizumab)
货号
GM-88265AB
规格
10μg
100 μg
1mg
立即询价
产品简介
相关产品
Anti-IL1B×IL1A hIgG1 Bispecific Antibody(lutikizumab) (Catalog # GM-88265AB) was immobilized at 6 μg/ml (100 μL/well). Increasing concentrations of Biotinylated Human IL-1 alpha Protein; His-Avi Tag (Catalog # GM-88251RP) were added.
Human IL-1 alpha Protein; His Tag (Catalog # GM-88245RP) was immobilized at 2 μg/ml (100 μL/well). Increasing concentrations of Anti-IL1B×IL1A hIgG1 Bispecific Antibody(lutikizumab) (Catalog # GM-88265AB) were added.
Human IL-1 beta Protein; His Tag (Catalog # GM-88248RP) was immobilized at 2 μg/ml (100 μL/well). Increasing concentrations of Anti-IL1B×IL1A hIgG1 Bispecific Antibody(lutikizumab) (Catalog # GM-88265AB) were added.
产品简介

Species Reactivity      Human

Clone                           lutikizumab

Source/Isotype           Human IgG1(L234A,L235A,D356E,L358M), kappa

Application                 Bioactivity-ELISA

Specificity                   Detects IL1B / IL1A

Gene                            IL1B; IL1A

Other Names              IL1B: IL-1, IL1-BETA, IL1F2, IL1beta
                                    IL1A: IL-1 alpha, IL-1A, IL1, IL1-ALPHA,

                                    IL1F1

Gene ID                       IL1B (3553);IL1A (3552)

Background                IL1A and IL1B belong to the same IL-1 cytokine family and are located adjacent to the Q13 region of human chromosome 2 Lutikizumab is an anti-il-1α and il-1β bivariate domain immunoglobulin that centrally targets two key proinflammatory cytokines, il-1α and il-1β, and has been shown to inhibit the production of il-1α and il-1β, a series of clinical studies have been carried out in the field of osteoarthritis (especially synovitis subtypes) by blocking IL-1 pathway-mediated inflammatory response through precise dual-target recognition and inhibition mechanisms, it provides a new direction for the treatment exploration of inflammatory phenotype osteoarthritis.

Storage                        Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation                Phosphate-buffered solution, pH 7.2-7.4.

Endotoxin                   < 1 EU/mg, determined by LAL gel clotting assay

Species Reactivity      Human

Clone                           lutikizumab

Source/Isotype           Human IgG1(L234A,L235A,D356E,L358M), kappa

Application                 Bioactivity-ELISA

Specificity                   Detects IL1B / IL1A

Gene                            IL1B; IL1A

Other Names              IL1B: IL-1, IL1-BETA, IL1F2, IL1beta
                                    IL1A: IL-1 alpha, IL-1A, IL1, IL1-ALPHA,

                                    IL1F1

Gene ID                       IL1B (3553);IL1A (3552)

Background                IL1A and IL1B belong to the same IL-1 cytokine family and are located adjacent to the Q13 region of human chromosome 2 Lutikizumab is an anti-il-1α and il-1β bivariate domain immunoglobulin that centrally targets two key proinflammatory cytokines, il-1α and il-1β, and has been shown to inhibit the production of il-1α and il-1β, a series of clinical studies have been carried out in the field of osteoarthritis (especially synovitis subtypes) by blocking IL-1 pathway-mediated inflammatory response through precise dual-target recognition and inhibition mechanisms, it provides a new direction for the treatment exploration of inflammatory phenotype osteoarthritis.

Storage                        Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation                Phosphate-buffered solution, pH 7.2-7.4.

Endotoxin                   < 1 EU/mg, determined by LAL gel clotting assay

相关产品
Tel: 400-627-9288
留言咨询
重置
提交
客服
微信
电话
留言
留言咨询
重置
提交